[1]
Kuc-Rajca , M. and Walaszkowska-Czyż , A. 2017. Lapatinib in the treatment of advanced HER2-positive breast cancer. OncoReview. 7, 3(27) (Aug. 2017), 144-149. DOI:https://doi.org/10.24292/01.OR.170817.